Asia Pacific Enteral and Parenteral Medical Nutrition Market Forecast to 2028

Asia Pacific Enteral and Parenteral Medical Nutrition Market Forecast to 2028 – Regional Analysis By Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer’s Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18-60 Years, 3-18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)

Send Enquiry
Item ID: BMIRE00028869 Category: Tags: , ,

$2,100$3,500

Description

The Asia Pacific enteral and parenteral medical nutrition market is expected to grow from US$ 2,339.32 million in 2023 to US$ 3,352.69 million by 2028. It is estimated to grow at a CAGR of 7.5% from 2023 to 2028.
Growing Strategic Initiatives by Companies Fuels Asia Pacific Enteral and Parenteral Medical Nutrition Market
Companies operating in the enteral and parenteral medical nutrition market constantly focus on strategic developments such as collaborations, expansions, agreements, partnerships, and new product launches, which help them improve their sales, expand their geographic reach, and enhance their capacities to cater to a greater than existing customer base. A few of the noteworthy developments in the enteral and parenteral medical nutrition market are mentioned such as- In June 2022, Nestle Health Science acquired The Better Health Company (TBHC) from CDH Investments and TBHC founding shareholders. The acquisition includes the GO Healthy brand, along with its vitamin and supplement lineups; the Manuka honey brand Egmont; and New Zealand Health Manufacturing, an Auckland-based manufacturing facility for vitamins, minerals, and supplements. The acquisition helped Nestle Health Science strengthen and expand its presence in New Zealand, Australia, and other Asia Pacific countries. In September 2021, Abbott introduced plant-based protein and organic food ingredients—PediaSure Harvest and Ensure Harvest—for people relying on feeding tubes. Harvest products can be used as sole-source nutrition or a supplement to satisfy daily nutrition requirements. In December 2020, Abbott launched the Pedialyte Hydration Solution, a new formulation designed with key nutrients to support immune health. Pedialyte with immune support includes prebiotics, vitamin B12, vitamin C, vitamin E, and zinc, specifically chosen for their importance in the development and improvement of the immune system. In October 2020, Nutricia (part of Danone) acquired Real Food Blends. The company helps contribute to the real food blends mission and portfolio by bringing more unique and nutritious choices to children and adults dependent on feeding tubes. Therefore, introducing products such as ready-to-drink and ready-to-use nutritional supplements; the development of innovative products targeting various health issues; and strategic moves such as expansions and acquisitions allow companies in the enteral and parenteral medical nutrition market to create new or improved products and new business to remain competitive in the market. Thus, such strategic growth initiatives create significant growth opportunities in the market.
Asia Pacific Enteral and Parenteral Medical Nutrition Market Overview
Asia Pacific (APAC) is the fastest-growing regional market for enteral and parenteral medical nutrition and is segmented into China, Japan, India, South Korea, Australia, Indonesia, Thailand, Vietnam, and the Rest of Asia Pacific. Factors contributing to the growth of the market in the region are the rising prevalence of chronic diseases and the growing presence of market players across the region, conferring the highest manufacturing of enteral & parenteral nutrition products. Furthermore, supportive government initiatives and research in the field of nutrition boost market growth.
Asia Pacific Enteral and Parenteral Medical Nutrition Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Enteral and Parenteral Medical Nutrition Market Segmentation
The Asia Pacific enteral and parenteral medical nutrition market is segmented into indication, nutrition type, form, product type, route of administration, age group, and distribution channel, and country.
Based on indication, the Asia Pacific enteral and parenteral medical nutrition market is segmented into elderly, gastrointestinal disorders, diabetes, cancer, respiratory disorders, alzheimer’s disease, dementia, renal disease, liver failure, post covid-19, and other indications. The elderly segment held the largest share of the Asia Pacific enteral and parenteral medical nutrition market in 2023. Gastrointestinal disorders are segmented into IBD, IBS, and others.
Based on nutrition type, the Asia Pacific enteral and parenteral medical nutrition market is segmented into supplemental and sole source. The supplemental segment held a larger share of the Asia Pacific enteral and parenteral medical nutrition market in 2023.
Based on form, the Asia Pacific enteral and parenteral medical nutrition market is segmented into liquid, powder, and semi solid. The liquid segment held the largest share of the Asia Pacific enteral and parenteral medical nutrition market in 2023.
Based on product type, the Asia Pacific enteral and parenteral medical nutrition market is segmented into general and disease specific. The general segment held the largest share of the Asia Pacific enteral and parenteral medical nutrition market in 2023.
Based on route of administration, the Asia Pacific enteral and parenteral medical nutrition market is segmented into oral, tube feed, and parenteral. The parenteral segment held the largest share of the Asia Pacific enteral and parenteral medical nutrition market in 2023.
Based on age group, the Asia Pacific enteral and parenteral medical nutrition market is segmented into above 60 years, 18-60 years, 3-18 years, and below 3 years. The above 60 years segment held the largest share of the Asia Pacific enteral and parenteral medical nutrition market in 2023.
Based on distribution channel, the Asia Pacific enteral and parenteral medical nutrition market is segmented into a hospital pharmacies, retail stores, e-commerce, and others. The hospital pharmacies segment held the largest share of the Asia Pacific enteral and parenteral medical nutrition market in 2023
Based on country, the Asia Pacific enteral and parenteral medical nutrition market is segmented into China, Japan, India, Australia, South Korea, Indonesia, Thailand, Vietnam, and the Rest of Asia Pacific. China dominated the share of the Asia Pacific enteral and parenteral medical nutrition market in 2023.
Abbott Laboratories; B. Braun SE; Baxter International Inc; Fresenius Kabi AG; Nestle SA; and Nutricia International BV are some of the leading companies operating in the Asia Pacific enteral and parenteral medical nutrition market.

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

At 7.5% CAGR, the Asia Pacific Enteral and Parenteral Medical Nutrition Market is speculated to be worth US$ 3,352.69 million by 2028, saysthe research team
According tothe research team’ research, the Asia Pacific enteral and parenteral medical nutrition market was valued at US$ 2,339.32 million in 2023 and is expected to reach US$ 3,352.69 million by 2028, registering a CAGR of 7.5% from 2023 to 2028. Rise in prevalence of gastrointestinal diseases and increasing cases of malnutrition and premature births are the critical factors attributed to the Asia Pacific enteral and parenteral medical nutrition market expansion.
There is a surge in the demand for products that help consumers proactively manage their health, especially those focused on specific needs in terms of energy levels, immunity, and disease treatment. Nutritional requirements differ based on the type of illness. Functionality and specific formulations of the enteral and parenteral products do not interfere with the existing treatment provided to patients and help deliver a more precise and enhanced treatment as per the requirement. The macro and micronutrient formulations of enteral and parenteral nutrition and its applications vary based on various diseases, such as cancer and gastrointestinal diseases. Isocaloric enteral nutrition formulation (1 kcal/ml) is generally prescribed to achieve estimated or measured caloric goals, while energy-dense formulae (>1 kcal/ml) are prescribed to increase calorie delivery in patients with gastrointestinal dysfunction. Moreover, pharmaceutical companies provide enteral and parenteral nutrition with individualized (patient-specific) constituents. Standardized parenteral nutrition products contain fixed constituents and are designed to meet the average patient’s nutritional requirements considering different requirements in different age groups. These nutrition products can be sourced as institution-specific standardized formulations or patient-specific formulations. For example, Impact (offered by Nestle) is a clinically proven nutritional solution for managing patients undergoing major elective surgeries to reduce postoperative complications and hospital stay duration and improve clinical outcomes. Peptamen Formula (Nestle) is the only peptide-based formula with enzymatically hydrolyzed 100% whey protein that helps overcome tube-feeding intolerance. Such tube-feeding formulas are specialized enteral nutrition products designed to support absorption and overcome tolerance mechanisms in individuals with gastrointestinal disorders. Calogen by Nutricia is a high-energy, long-chain triglyceride fat emulsion oral nutritional supplement used to manage conditions requiring a high energy intake. Various organizations are making efforts to spread awareness of the use of specific nutritional formulations.
Further, a surge in the number of people turning to plant-based food triggers the demand for plant-based nutrition products worldwide. People are more likely to show intolerance to artificial/synthetically sourced ingredients used in higher numbers, which may lead to adverse reactions. Thus, the fewer ingredients, the better the final product. The Innova Consumer Survey 2020 showed that health, diet variety, sustainability, and taste are among the top reasons why people consider plant-based alternatives. According to Abbott, consumers and patients relying on tube feeding are no exception to this trend. For instance, in August 2021, Kate Farms launched the first closed feeding system delivering plant-based formulas in a ready-to-hang 1-liter bag. Kate Farms Standard 1.4 plain and Peptide 1.5 plain formulations are plant-based, organic, calorically dense products, which are used as a sole source of supplemental nutrition in tube feeding. In September 2021, Abbott introduced a portfolio of plant-based proteins and organic food ingredients for children and adults. Similarly, olive oil-based parenteral nutrition products are also gaining popularity. Therefore, functional, and patient-centric formulations and plant-based nutrition products are the prime emerging trends in the enteral and parenteral medical nutrition market.
On the contrary, mechanical, gastrointestinal, and metabolic complications associated with enteral and parenteral feeding systems, and limitations related to catheter placement hampers the Asia Pacific Enteral and Parenteral Medical Nutrition Market.
Based on indication, the Asia Pacific enteral and parenteral medical nutrition market is segmented into elderly, gastrointestinal disorders, diabetes, cancer, respiratory disorders, alzheimer’s disease, dementia, renal disease, liver failure, post covid-19, and other indications. The elderly segment held 30.4% share of Asia Pacific Enteral and Parenteral Medical Nutrition Market in 2023, amassing US$ 710.48 million. It is projected to garner US$ 1,028.57 million by 2028 to expand at 7.7% CAGR during 2023-2028.
Based on nutrition type, the Asia Pacific enteral and parenteral medical nutrition market is segmented into supplemental and sole source. The supplemental segment held 79.0% share of Asia Pacific Enteral and Parenteral Medical Nutrition Market in 2023, amassing US$ 1,848.53 million. It is projected to garner US$ 2,631.51 million by 2028 to expand at 7.3% CAGR during 2023-2028.
Based on form, the Asia Pacific enteral and parenteral medical nutrition market is segmented into liquid, powder, and semi solid. The liquid segment held 53.1% share of Asia Pacific Enteral and Parenteral Medical Nutrition Market in 2023, amassing US$ 1,242.39 million. It is projected to garner US$ 1,768.59 million by 2028 to expand at 7.3% CAGR during 2023-2028.
Based on product type, the Asia Pacific enteral and parenteral medical nutrition market is segmented into general and disease specific. The general segment held 57.7% share of Asia Pacific Enteral and Parenteral Medical Nutrition Market in 2023, amassing US$ 1,350.91 million. It is projected to garner US$ 1,952.70 million by 2028 to expand at 7.6% CAGR during 2023-2028.
Based on route of administration, the Asia Pacific enteral and parenteral medical nutrition market is segmented into oral, tube feed, and parenteral. The parenteral segment held 43.9% share of Asia Pacific Enteral and Parenteral Medical Nutrition Market in 2023, amassing US$ 1,026.10 million. It is projected to garner US$ 1,461.14 million by 2028 to expand at 7.3% CAGR during 2023-2028.
Based on age group, the Asia Pacific enteral and parenteral medical nutrition market is segmented into above 60 years, 18-60 years, 3-18 years, and below 3 years. The above 60 years segment held 39.4% share of Asia Pacific Enteral and Parenteral Medical Nutrition Market in 2023, amassing US$ 922.58 million. It is projected to garner US$ 1,326.92 million by 2028 to expand at 7.5% CAGR during 2023-2028.
Based on distribution channel, the Asia Pacific enteral and parenteral medical nutrition market is segmented into a hospital pharmacies, retail stores, e-commerce, and others. The hospital pharmacies segment held 41.0% share of Asia Pacific Enteral and Parenteral Medical Nutrition Market in 2023, amassing US$ 960.17 million. It is projected to garner US$ 1,360.33 million by 2028 to expand at 7.2% CAGR during 2023-2028.
Based on country, the Asia Pacific enteral and parenteral medical nutrition market has been categorized into China, Japan, India, Australia, South Korea, Indonesia, Thailand, Vietnam, and the Rest of Asia Pacific. Our regional analysis states that China captured 24.6% share of Asia Pacific Enteral and Parenteral Medical Nutrition Market in 2023. It was assessed at US$ 574.68 million in 2023 and is likely to hit US$ 842.84 million by 2028, exhibiting a CAGR of 8.0% during the forecast period.
Key players operating in the Asia Pacific enteral and parenteral medical nutrition market are Abbott Laboratories; B. Braun SE; Baxter International Inc; Fresenius Kabi AG; Nestle SA; and Nutricia International BV, among others.
November 2021, Abbott Launched Similac 360 Total Care to Support the Immune System, Digestive Health and Brain Development. Similac 360 Total Care is the first and only infant formula in the U.S. with a blend of five different HMOs, previously only found together in breast milk. This formula is designed to provide nutrition to support the whole baby’s health and development, including the developing immune system, digestive system and brain.

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Enteral and Parenteral Medical Nutrition Market – By Indication
1.3.2 Asia Pacific Enteral and Parenteral Medical Nutrition Market – By Nutrition Type
1.3.3 Asia Pacific Enteral and Parenteral Medical Nutrition Market – By Form
1.3.4 Asia Pacific Enteral and Parenteral Medical Nutrition Market – By Product Type
1.3.5 Asia Pacific Enteral and Parenteral Medical Nutrition Market – By Route of Administration
1.3.6 Asia Pacific Enteral and Parenteral Medical Nutrition Market – By Age Group
1.3.7 Asia Pacific Enteral and Parenteral Medical Nutrition Market – By Distribution Channel
1.3.8 Asia Pacific Enteral and Parenteral Medical Nutrition Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Enteral and Parenteral Medical Nutrition Market – Market Landscape
4.1 Overview
4.2 Asia Pacific PEST Analysis
4.3 Experts Opinion
4.4 Energy Content Analysis
4.4.1 Lower than 1.5 kcal/ml
4.4.2 Equals to 1.5 kcal/ml
4.4.3 Lower than 2kcal/ml:
4.4.4 Equal to or Higher than 2kcal/ml:
5. Asia Pacific Enteral and Parenteral Medical Nutrition Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in Prevalence of Gastrointestinal Diseases
5.1.2 Increasing Cases of Malnutrition and Premature Births
5.2 Market Restraints
5.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Enteral and Parenteral Feeding Systems, and Limitations Related to Catheter Placement
5.3 Market Opportunities
5.3.1 Growing Strategic Initiatives by Companies
5.4 Future Trends
5.4.1 Specific Formulations and Plant-Based Nutrition Products
5.5 Impact Analysis
6. Enteral and Parenteral Medical Nutrition Market – Asia Pacific Analysis
6.1 Asia Pacific Enteral and Parenteral Medical Nutrition Market Revenue Forecast and Analysis
7. Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 – by Indication
7.1 Overview
7.2 Asia Pacific Enteral and Parenteral Medical Nutrition Market Revenue Share, by Indication 2022 & 2028 (%)
7.3 Elderly
7.3.1 Overview
7.3.2 Elderly: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Elderly by Form, 2020-2028 (US$ Million)
7.4 Gastrointestinal Disorders
7.4.1 Overview
7.4.2 Gastrointestinal Disorders: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.1 Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Form, 2020-2028 (US$ Million)
7.4.3 Inflammatory Bowel Disease
7.4.3.1 Overview
7.4.3.2 IBD: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3.2.1 Asia Pacific Enteral and Parenteral Medical Nutrition Market, For IBD by Form, 2020-2028 (US$ Million)
7.4.4 Irritable Bowel Syndrome
7.4.4.1 Overview
7.4.4.2 IBS: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4.2.1 Asia Pacific Enteral and Parenteral Medical Nutrition Market, For IBS by Form, 2020-2028 (US$ Million)
7.4.5 Others
7.4.5.1 Overview
7.4.5.2 Others: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
7.4.5.2.1 Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Others by Form, 2020-2028 (US$ Million)
7.5 Diabetes
7.5.1 Overview
7.5.2 Diabetes: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.1.1 Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Diabetes by Form, 2020-2028 (US$ Million)
7.6 Cancer
7.6.1 Overview
7.6.2 Cancer: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
7.6.2.1 Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Cancer by Form, 2020-2028 (US$ Million)
7.7 Respiratory Disorders
7.7.1 Overview
7.7.2 Respiratory Disorders: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
7.7.2.1 Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Respiratory Disorders by Form, 2020-2028 (US$ Million)
7.8 Alzheimer’s Disease
7.8.1 Overview
7.8.2 Alzheimer’s Disease: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
7.8.2.1 Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Alzheimer’s Disease by Form, 2020-2028 (US$ Million)
7.9 Dementia
7.9.1 Overview
7.9.2 Dementia: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
7.9.2.1 Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Dementia by Form, 2020-2028 (US$ Million)
7.10 Renal Disease
7.10.1 Overview
7.10.2 Renal Disease: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
7.10.2.1 Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Renal Disease by Form, 2020-2028 (US$ Million)
7.11 Liver Failure
7.11.1 Overview
7.11.2 Liver Failure: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
7.11.2.1 Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Liver Failure by Form, 2020-2028 (US$ Million)
7.12 Post COVID-19
7.12.1 Overview
7.12.2 Post COVID-19: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
7.12.2.1 Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Post COVID-19 by Form, 2020-2028 (US$ Million)
7.13 Other Indications
7.13.1 Overview
7.13.2 Other Indications: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
7.13.2.1 Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Other Indications by Form, 2020-2028 (US$ Million)
8. Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 – by Nutrition Type
8.1 Overview
8.2 Asia Pacific Enteral and Parenteral Medical Nutrition Market Revenue Share, by Nutrition Type 2022 & 2028 (%)
8.3 Supplemental
8.3.1 Overview
8.3.2 Supplemental: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Sole Source
8.4.1 Overview
8.4.2 Sole Source: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
9. Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 – by Form
9.1 Overview
9.2 Asia Pacific Enteral and Parenteral Medical Nutrition Market Revenue Share, by Form 2022 & 2028 (%)
9.3 Liquid
9.3.1 Overview
9.3.2 Liquid: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Powder
9.4.1 Overview
9.4.2 Powder: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Semi-Solid
9.5.1 Overview
9.5.2 Semi-Solid: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
10. Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 – by Product Type
10.1 Overview
10.2 Asia Pacific Enteral and Parenteral Medical Nutrition Market Revenue Share, by Product Type 2022 & 2028 (%)
10.3 General
10.3.1 Overview
10.3.2 General: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Disease Specific
10.4.1 Overview
10.4.2 Disease Specific: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
11. Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 – by Route of Administration
11.1 Overview
11.2 Asia Pacific Enteral and Parenteral Medical Nutrition Market Revenue Share, by Route of Administration 2022 & 2028 (%)
11.3 Oral
11.3.1 Overview
11.3.2 Oral: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
11.4 Tube Feed
11.4.1 Overview
11.4.2 Tube Feed: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
11.5 Parenteral
11.5.1 Overview
11.5.2 Parenteral: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
12. Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 – by Age Group
12.1 Overview
12.2 Asia Pacific Enteral and Parenteral Medical Nutrition Market Revenue Share, by Age Group 2022 & 2028 (%)
12.3 Above 60 Years
12.3.1 Overview
12.3.2 Above 60 Years: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
12.4-60 Years
12.4.1 Overview
12.4.2-60 Years: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
12.5 3-18 Years
12.5.1 Overview
12.5.2 3-18 Years: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
12.6 Below 3 Years
12.6.1 Overview
12.6.2 Below 3 Years: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
13. Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 – by Distribution Channel
13.1 Overview
13.2 Asia Pacific Enteral and Parenteral Medical Nutrition Market Revenue Share, by Distribution Channel 2022 & 2028 (%)
13.3 Hospital Pharmacies
13.3.1 Overview
13.3.2 Hospital Pharmacies: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
13.4 Retail Stores
13.4.1 Overview
13.4.2 Retail Stores: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
13.5 E-Commerce
13.5.1 Overview
13.5.2 E-Commerce: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
13.6 Others
13.6.1 Overview
13.6.2 Others: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
14. Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 – Country Analysis
14.1 Overview
14.1.1 Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Key Country
14.1.1.1 China: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
14.1.1.1.1 Overview
14.1.1.1.2 China: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
14.1.1.1.3 China: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Indication, 2020-2028 (US$ Million)
14.1.1.1.3.1 China: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Indication, 2020-2028 (US$ Million)
14.1.1.1.3.2 China: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Elderly by Form, 2020-2028 (US$ Million)
14.1.1.1.3.3 China: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Form, 2020-2028 (US$ Million)
14.1.1.1.3.3.1 China: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For IBD by Form, 2020-2028 (US$ Million)
14.1.1.1.3.3.2 China: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For IBS by Form, 2020-2028 (US$ Million)
14.1.1.1.3.3.3 China: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Others by Form, 2020-2028 (US$ Million)
14.1.1.1.3.4 China: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Diabetes by Form, 2020-2028 (US$ Million)
14.1.1.1.3.5 China: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Cancer by Form, 2020-2028 (US$ Million)
14.1.1.1.3.6 China: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Respiratory Disorder by Form, 2020-2028 (US$ Million)
14.1.1.1.3.7 China: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Alzheimer’s Disease by Form, 2020-2028 (US$ Million)
14.1.1.1.3.8 China: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Dementia by Form, 2020-2028 (US$ Million)
14.1.1.1.3.9 China: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Renal Disease by Form, 2020-2028 (US$ Million)
14.1.1.1.3.10 China: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Liver Failure by Form, 2020-2028 (US$ Million)
14.1.1.1.3.11 China: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Post COVID-19 by Form, 2020-2028 (US$ Million)
14.1.1.1.3.12 China: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Other Indications by Form, 2020-2028 (US$ Million)
14.1.1.1.4 China: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Nutrition Type, 2020-2028 (US$ Million)
14.1.1.1.5 China: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Form, 2020-2028 (US$ Million)
14.1.1.1.6 China: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Product Type, 2020-2028 (US$ Million)
14.1.1.1.7 China: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Route of Administration, 2020-2028 (US$ Million)
14.1.1.1.8 China: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Age Group, 2020-2028 (US$ Million)
14.1.1.1.9 China: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Distribution Channel, 2020-2028 (US$ Million)
14.1.1.2 Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
14.1.1.2.1 Overview
14.1.1.2.2 Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
14.1.1.2.3 Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Indication, 2020-2028 (US$ Million)
14.1.1.2.3.1 Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Indication, 2020-2028 (US$ Million)
14.1.1.2.3.2 Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Elderly by Form, 2020-2028 (US$ Million)
14.1.1.2.3.3 Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Form, 2020-2028 (US$ Million)
14.1.1.2.3.3.1 Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For IBD by Form, 2020-2028 (US$ Million)
14.1.1.2.3.3.2 Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For IBS by Form, 2020-2028 (US$ Million)
14.1.1.2.3.3.3 Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Others by Form, 2020-2028 (US$ Million)
14.1.1.2.3.4 Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Diabetes by Form, 2020-2028 (US$ Million)
14.1.1.2.3.5 Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Cancer by Form, 2020-2028 (US$ Million)
14.1.1.2.3.6 Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Respiratory Disorder by Form, 2020-2028 (US$ Million)
14.1.1.2.3.7 Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Alzheimer’s Disease by Form, 2020-2028 (US$ Million)
14.1.1.2.3.8 Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Dementia by Form, 2020-2028 (US$ Million)
14.1.1.2.3.9 Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Renal Disease by Form, 2020-2028 (US$ Million)
14.1.1.2.3.10 Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Liver Failure by Form, 2020-2028 (US$ Million)
14.1.1.2.3.11 Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Post COVID-19 by Form, 2020-2028 (US$ Million)
14.1.1.2.3.12 Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Other Indications by Form, 2020-2028 (US$ Million)
14.1.1.2.4 Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Nutrition Type, 2020-2028 (US$ Million)
14.1.1.2.5 Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Form, 2020-2028 (US$ Million)
14.1.1.2.6 Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Product Type, 2020-2028 (US$ Million)
14.1.1.2.7 Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Route of Administration, 2020-2028 (US$ Million)
14.1.1.2.8 Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Age Group, 2020-2028 (US$ Million)
14.1.1.2.9 Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Distribution Channel, 2020-2028 (US$ Million)
14.1.1.3 India: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
14.1.1.3.1 Overview
14.1.1.3.2 India: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
14.1.1.3.3 India: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Indication, 2020-2028 (US$ Million)
14.1.1.3.3.1 India: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Indication, 2020-2028 (US$ Million)
14.1.1.3.3.2 India: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Elderly by Form, 2020-2028 (US$ Million)
14.1.1.3.3.3 India: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Form, 2020-2028 (US$ Million)
14.1.1.3.3.3.1 India: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For IBD by Form, 2020-2028 (US$ Million)
14.1.1.3.3.3.2 India: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For IBS by Form, 2020-2028 (US$ Million)
14.1.1.3.3.3.3 India: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Others by Form, 2020-2028 (US$ Million)
14.1.1.3.3.4 India: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Diabetes by Form, 2020-2028 (US$ Million)
14.1.1.3.3.5 India: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Cancer by Form, 2020-2028 (US$ Million)
14.1.1.3.3.6 India: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Respiratory Disorder by Form, 2020-2028 (US$ Million)
14.1.1.3.3.7 India: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Alzheimer’s Disease by Form, 2020-2028 (US$ Million)
14.1.1.3.3.8 India: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Dementia by Form, 2020-2028 (US$ Million)
14.1.1.3.3.9 India: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Renal Disease by Form, 2020-2028 (US$ Million)
14.1.1.3.3.10 India: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Liver Failure by Form, 2020-2028 (US$ Million)
14.1.1.3.3.11 India: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Post COVID-19 by Form, 2020-2028 (US$ Million)
14.1.1.3.3.12 India: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Other Indications by Form, 2020-2028 (US$ Million)
14.1.1.3.4 India: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Nutrition Type, 2020-2028 (US$ Million)
14.1.1.3.5 India: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Form, 2020-2028 (US$ Million)
14.1.1.3.6 India: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Product Type, 2020-2028 (US$ Million)
14.1.1.3.7 India: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Route of Administration, 2020-2028 (US$ Million)
14.1.1.3.8 India: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Age Group, 2020-2028 (US$ Million)
14.1.1.3.9 India: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Distribution Channel, 2020-2028 (US$ Million)
14.1.1.4 Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
14.1.1.4.1 Overview
14.1.1.4.2 Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
14.1.1.4.3 Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Indication, 2020-2028 (US$ Million)
14.1.1.4.3.1 Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Indication, 2020-2028 (US$ Million)
14.1.1.4.3.2 Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Elderly by Form, 2020-2028 (US$ Million)
14.1.1.4.3.3 Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Form, 2020-2028 (US$ Million)
14.1.1.4.3.3.1 Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For IBD by Form, 2020-2028 (US$ Million)
14.1.1.4.3.3.2 Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For IBS by Form, 2020-2028 (US$ Million)
14.1.1.4.3.3.3 Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Others by Form, 2020-2028 (US$ Million)
14.1.1.4.3.4 Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Diabetes by Form, 2020-2028 (US$ Million)
14.1.1.4.3.5 Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Cancer by Form, 2020-2028 (US$ Million)
14.1.1.4.3.6 Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Respiratory Disorder by Form, 2020-2028 (US$ Million)
14.1.1.4.3.7 Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Alzheimer’s Disease by Form, 2020-2028 (US$ Million)
14.1.1.4.3.8 Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Dementia by Form, 2020-2028 (US$ Million)
14.1.1.4.3.9 Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Renal Disease by Form, 2020-2028 (US$ Million)
14.1.1.4.3.10 Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Liver Failure by Form, 2020-2028 (US$ Million)
14.1.1.4.3.11 Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Post COVID-19 by Form, 2020-2028 (US$ Million)
14.1.1.4.3.12 Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Other Indications by Form, 2020-2028 (US$ Million)
14.1.1.4.4 Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Nutrition Type, 2020-2028 (US$ Million)
14.1.1.4.5 Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Form, 2020-2028 (US$ Million)
14.1.1.4.6 Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Product Type, 2020-2028 (US$ Million)
14.1.1.4.7 Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Route of Administration, 2020-2028 (US$ Million)
14.1.1.4.8 Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Age Group, 2020-2028 (US$ Million)
14.1.1.4.9 Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Distribution Channel, 2020-2028 (US$ Million)
14.1.1.5 South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
14.1.1.5.1 Overview
14.1.1.5.2 South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
14.1.1.5.3 South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Indication, 2020-2028 (US$ Million)
14.1.1.5.3.1 South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Indication, 2020-2028 (US$ Million)
14.1.1.5.3.2 South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Elderly by Form, 2020-2028 (US$ Million)
14.1.1.5.3.3 South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Form, 2020-2028 (US$ Million)
14.1.1.5.3.3.1 South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For IBD by Form, 2020-2028 (US$ Million)
14.1.1.5.3.3.2 South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For IBS by Form, 2020-2028 (US$ Million)
14.1.1.5.3.3.3 South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Others by Form, 2020-2028 (US$ Million)
14.1.1.5.3.4 South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Diabetes by Form, 2020-2028 (US$ Million)
14.1.1.5.3.5 South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Cancer by Form, 2020-2028 (US$ Million)
14.1.1.5.3.6 South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Respiratory Disorder by Form, 2020-2028 (US$ Million)
14.1.1.5.3.7 South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Alzheimer’s Disease by Form, 2020-2028 (US$ Million)
14.1.1.5.3.8 South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Dementia by Form, 2020-2028 (US$ Million)
14.1.1.5.3.9 South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Renal Disease by Form, 2020-2028 (US$ Million)
14.1.1.5.3.10 South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Liver Failure by Form, 2020-2028 (US$ Million)
14.1.1.5.3.11 South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Post COVID-19 by Form, 2020-2028 (US$ Million)
14.1.1.5.3.12 South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Other Indications by Form, 2020-2028 (US$ Million)
14.1.1.5.4 South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Nutrition Type, 2020-2028 (US$ Million)
14.1.1.5.5 South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Form, 2020-2028 (US$ Million)
14.1.1.5.6 South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Product Type, 2020-2028 (US$ Million)
14.1.1.5.7 South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Route of Administration, 2020-2028 (US$ Million)
14.1.1.5.8 South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Age Group, 2020-2028 (US$ Million)
14.1.1.5.9 South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Distribution Channel, 2020-2028 (US$ Million)
14.1.1.6 Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
14.1.1.6.1 Overview
14.1.1.6.2 Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
14.1.1.6.3 Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Indication, 2020-2028 (US$ Million)
14.1.1.6.3.1 Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Indication, 2020-2028 (US$ Million)
14.1.1.6.3.2 Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Elderly by Form, 2020-2028 (US$ Million)
14.1.1.6.3.3 Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Form, 2020-2028 (US$ Million)
14.1.1.6.3.3.1 Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For IBD by Form, 2020-2028 (US$ Million)
14.1.1.6.3.3.2 Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For IBS by Form, 2020-2028 (US$ Million)
14.1.1.6.3.3.3 Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Others by Form, 2020-2028 (US$ Million)
14.1.1.6.3.4 Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Diabetes by Form, 2020-2028 (US$ Million)
14.1.1.6.3.5 Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Cancer by Form, 2020-2028 (US$ Million)
14.1.1.6.3.6 Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Respiratory Disorder by Form, 2020-2028 (US$ Million)
14.1.1.6.3.7 Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Alzheimer’s Disease by Form, 2020-2028 (US$ Million)
14.1.1.6.3.8 Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Dementia by Form, 2020-2028 (US$ Million)
14.1.1.6.3.9 Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Renal Disease by Form, 2020-2028 (US$ Million)
14.1.1.6.3.10 Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Liver Failure by Form, 2020-2028 (US$ Million)
14.1.1.6.3.11 Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Post COVID-19 by Form, 2020-2028 (US$ Million)
14.1.1.6.3.12 Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Other Indications by Form, 2020-2028 (US$ Million)
14.1.1.6.4 Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Nutrition Type, 2020-2028 (US$ Million)
14.1.1.6.5 Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Form, 2020-2028 (US$ Million)
14.1.1.6.6 Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Product Type, 2020-2028 (US$ Million)
14.1.1.6.7 Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Route of Administration, 2020-2028 (US$ Million)
14.1.1.6.8 Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Age Group, 2020-2028 (US$ Million)
14.1.1.6.9 Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Distribution Channel, 2020-2028 (US$ Million)
14.1.1.7 Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
14.1.1.7.1 Overview
14.1.1.7.2 Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
14.1.1.7.3 Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Indication, 2020-2028 (US$ Million)
14.1.1.7.3.1 Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Indication, 2020-2028 (US$ Million)
14.1.1.7.3.2 Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Elderly by Form, 2020-2028 (US$ Million)
14.1.1.7.3.3 Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Form, 2020-2028 (US$ Million)
14.1.1.7.3.3.1 Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For IBD by Form, 2020-2028 (US$ Million)
14.1.1.7.3.3.2 Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For IBS by Form, 2020-2028 (US$ Million)
14.1.1.7.3.3.3 Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Others by Form, 2020-2028 (US$ Million)
14.1.1.7.3.4 Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Diabetes by Form, 2020-2028 (US$ Million)
14.1.1.7.3.5 Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Cancer by Form, 2020-2028 (US$ Million)
14.1.1.7.3.6 Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Respiratory Disorder by Form, 2020-2028 (US$ Million)
14.1.1.7.3.7 Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Alzheimer’s Disease by Form, 2020-2028 (US$ Million)
14.1.1.7.3.8 Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Dementia by Form, 2020-2028 (US$ Million)
14.1.1.7.3.9 Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Renal Disease by Form, 2020-2028 (US$ Million)
14.1.1.7.3.10 Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Liver Failure by Form, 20

LIST OF TABLES

Table 1. Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Elderly by Form – Revenue and Forecast to 2028 (US$ Million)
Table 2. Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Form – Revenue and Forecast to 2028 (US$ Million)
Table 3. Asia Pacific Enteral and Parenteral Medical Nutrition Market, For IBD by Form – Revenue and Forecast to 2028 (US$ Million)
Table 4. Asia Pacific Enteral and Parenteral Medical Nutrition Market, For IBS by Form – Revenue and Forecast to 2028 (US$ Million)
Table 5. Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Others by Form – Revenue and Forecast to 2028 (US$ Million)
Table 6. Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Diabetes by Form – Revenue and Forecast to 2028 (US$ Million)
Table 7. Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Cancer by Form – Revenue and Forecast to 2028 (US$ Million)
Table 8. Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Respiratory Disorders by Form – Revenue and Forecast to 2028 (US$ Million)
Table 9. Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Alzheimer’s Disease by Form – Revenue and Forecast to 2028 (US$ Million)
Table 10. Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Dementia by Form – Revenue and Forecast to 2028 (US$ Million)
Table 11. Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Renal Disease by Form – Revenue and Forecast to 2028 (US$ Million)
Table 12. Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Liver Failure by Form – Revenue and Forecast to 2028 (US$ Million)
Table 13. Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Post COVID-19 by Form – Revenue and Forecast to 2028 (US$ Million)
Table 14. Asia Pacific Enteral and Parenteral Medical Nutrition Market, For Other Indications by Form – Revenue and Forecast to 2028 (US$ Million)
Table 15. China: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 16. China: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Gastrointestinal Disorders by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 17. China: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Elderly by Form – Revenue and Forecast to 2028 (US$ Million)
Table 18. China: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Gastrointestinal Disorders by Form – Revenue and Forecast to 2028 (US$ Million)
Table 19. China: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For IBD by Form – Revenue and Forecast to 2028 (US$ Million)
Table 20. China: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For IBS by Form – Revenue and Forecast to 2028 (US$ Million)
Table 21. China: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Others by Form – Revenue and Forecast to 2028 (US$ Million)
Table 22. China: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Diabetes by Form – Revenue and Forecast to 2028 (US$ Million)
Table 23. China: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Cancer by Form – Revenue and Forecast to 2028 (US$ Million)
Table 24. China: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Respiratory Disorder by Form – Revenue and Forecast to 2028 (US$ Million)
Table 25. China: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Alzheimer’s Disease by Form – Revenue and Forecast to 2028 (US$ Million)
Table 26. China: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Dementia by Form – Revenue and Forecast to 2028 (US$ Million)
Table 27. China: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Renal Disease by Form – Revenue and Forecast to 2028 (US$ Million)
Table 28. China: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Liver Failure by Form – Revenue and Forecast to 2028 (US$ Million)
Table 29. China: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Post COVID-19 by Form – Revenue and Forecast to 2028 (US$ Million)
Table 30. China: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Other Indications by Form – Revenue and Forecast to 2028 (US$ Million)
Table 31. China: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Nutrition Type – Revenue and Forecast to 2028 (US$ Million)
Table 32. China: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Form – Revenue and Forecast to 2028 (US$ Million)
Table 33. China: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 34. China: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 35. China: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Age Group – Revenue and Forecast to 2028 (US$ Million)
Table 36. China: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 37. Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 38. Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Gastrointestinal Disorders by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 39. Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Elderly by Form – Revenue and Forecast to 2028 (US$ Million)
Table 40. Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Gastrointestinal Disorders by Form – Revenue and Forecast to 2028 (US$ Million)
Table 41. Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For IBD by Form – Revenue and Forecast to 2028 (US$ Million)
Table 42. Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For IBS by Form – Revenue and Forecast to 2028 (US$ Million)
Table 43. Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Others by Form – Revenue and Forecast to 2028 (US$ Million)
Table 44. Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Diabetes by Form – Revenue and Forecast to 2028 (US$ Million)
Table 45. Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Cancer by Form – Revenue and Forecast to 2028 (US$ Million)
Table 46. Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Respiratory Disorder by Form – Revenue and Forecast to 2028 (US$ Million)
Table 47. Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Alzheimer’s Disease by Form – Revenue and Forecast to 2028 (US$ Million)
Table 48. Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Dementia by Form – Revenue and Forecast to 2028 (US$ Million)
Table 49. Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Renal Disease by Form – Revenue and Forecast to 2028 (US$ Million)
Table 50. Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Liver Failure by Form – Revenue and Forecast to 2028 (US$ Million)
Table 51. Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Post COVID-19 by Form – Revenue and Forecast to 2028 (US$ Million)
Table 52. Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Other Indications by Form – Revenue and Forecast to 2028 (US$ Million)
Table 53. Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Nutrition Type – Revenue and Forecast to 2028 (US$ Million)
Table 54. Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Form – Revenue and Forecast to 2028 (US$ Million)
Table 55. Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 56. Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 57. Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Age Group – Revenue and Forecast to 2028 (US$ Million)
Table 58. Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 59. India: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 60. India: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Gastrointestinal Disorders by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 61. India: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Elderly by Form – Revenue and Forecast to 2028 (US$ Million)
Table 62. India: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Gastrointestinal Disorders by Form – Revenue and Forecast to 2028 (US$ Million)
Table 63. India: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For IBD by Form – Revenue and Forecast to 2028 (US$ Million)
Table 64. India: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For IBS by Form – Revenue and Forecast to 2028 (US$ Million)
Table 65. India: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Others by Form – Revenue and Forecast to 2028 (US$ Million)
Table 66. India: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Diabetes by Form – Revenue and Forecast to 2028 (US$ Million)
Table 67. India: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Cancer by Form – Revenue and Forecast to 2028 (US$ Million)
Table 68. India: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Respiratory Disorder by Form – Revenue and Forecast to 2028 (US$ Million)
Table 69. India: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Alzheimer’s Disease by Form – Revenue and Forecast to 2028 (US$ Million)
Table 70. India: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Dementia by Form – Revenue and Forecast to 2028 (US$ Million)
Table 71. India: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Renal Disease by Form – Revenue and Forecast to 2028 (US$ Million)
Table 72. India: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Liver Failure by Form – Revenue and Forecast to 2028 (US$ Million)
Table 73. India: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Post COVID-19 by Form – Revenue and Forecast to 2028 (US$ Million)
Table 74. India: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Other Indications by Form – Revenue and Forecast to 2028 (US$ Million)
Table 75. India: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Nutrition Type – Revenue and Forecast to 2028 (US$ Million)
Table 76. India: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Form – Revenue and Forecast to 2028 (US$ Million)
Table 77. India: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 78. India: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 79. India: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Age Group – Revenue and Forecast to 2028 (US$ Million)
Table 80. India: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 81. Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 82. Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Gastrointestinal Disorders by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 83. Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Elderly by Form – Revenue and Forecast to 2028 (US$ Million)
Table 84. Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Gastrointestinal Disorders by Form – Revenue and Forecast to 2028 (US$ Million)
Table 85. Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For IBD by Form – Revenue and Forecast to 2028 (US$ Million)
Table 86. Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For IBS by Form – Revenue and Forecast to 2028 (US$ Million)
Table 87. Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Others by Form – Revenue and Forecast to 2028 (US$ Million)
Table 88. Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Diabetes by Form – Revenue and Forecast to 2028 (US$ Million)
Table 89. Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Cancer by Form – Revenue and Forecast to 2028 (US$ Million)
Table 90. Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Respiratory Disorder by Form – Revenue and Forecast to 2028 (US$ Million)
Table 91. Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Alzheimer’s Disease by Form – Revenue and Forecast to 2028 (US$ Million)
Table 92. Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Dementia by Form – Revenue and Forecast to 2028 (US$ Million)
Table 93. Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Renal Disease by Form – Revenue and Forecast to 2028 (US$ Million)
Table 94. Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Liver Failure by Form – Revenue and Forecast to 2028 (US$ Million)
Table 95. Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Post COVID-19 by Form – Revenue and Forecast to 2028 (US$ Million)
Table 96. Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Other Indications by Form – Revenue and Forecast to 2028 (US$ Million)
Table 97. Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Nutrition Type – Revenue and Forecast to 2028 (US$ Million)
Table 98. Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Form – Revenue and Forecast to 2028 (US$ Million)
Table 99. Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 100. Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 101. Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Age Group – Revenue and Forecast to 2028 (US$ Million)
Table 102. Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 103. South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 104. South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Gastrointestinal Disorders by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 105. South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Elderly by Form – Revenue and Forecast to 2028 (US$ Million)
Table 106. South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Gastrointestinal Disorders by Form – Revenue and Forecast to 2028 (US$ Million)
Table 107. South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For IBD by Form – Revenue and Forecast to 2028 (US$ Million)
Table 108. South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For IBS by Form – Revenue and Forecast to 2028 (US$ Million)
Table 109. South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Others by Form – Revenue and Forecast to 2028 (US$ Million)
Table 110. South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Diabetes by Form – Revenue and Forecast to 2028 (US$ Million)
Table 111. South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Cancer by Form – Revenue and Forecast to 2028 (US$ Million)
Table 112. South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Respiratory Disorder by Form – Revenue and Forecast to 2028 (US$ Million)
Table 113. South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Alzheimer’s Disease by Form – Revenue and Forecast to 2028 (US$ Million)
Table 114. South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Dementia by Form – Revenue and Forecast to 2028 (US$ Million)
Table 115. South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Renal Disease by Form – Revenue and Forecast to 2028 (US$ Million)
Table 116. South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Liver Failure by Form – Revenue and Forecast to 2028 (US$ Million)
Table 117. South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Post COVID-19 by Form – Revenue and Forecast to 2028 (US$ Million)
Table 118. South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Other Indications by Form – Revenue and Forecast to 2028 (US$ Million)
Table 119. South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Nutrition Type – Revenue and Forecast to 2028 (US$ Million)
Table 120. South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Form – Revenue and Forecast to 2028 (US$ Million)
Table 121. South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 122. South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 123. South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Age Group – Revenue and Forecast to 2028 (US$ Million)
Table 124. South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 125. Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 126. Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Gastrointestinal Disorders by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 127. Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Elderly by Form – Revenue and Forecast to 2028 (US$ Million)
Table 128. Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Gastrointestinal Disorders by Form – Revenue and Forecast to 2028 (US$ Million)
Table 129. Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For IBD by Form – Revenue and Forecast to 2028 (US$ Million)
Table 130. Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For IBS by Form – Revenue and Forecast to 2028 (US$ Million)
Table 131. Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Others by Form – Revenue and Forecast to 2028 (US$ Million)
Table 132. Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Diabetes by Form – Revenue and Forecast to 2028 (US$ Million)
Table 133. Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Cancer by Form – Revenue and Forecast to 2028 (US$ Million)
Table 134. Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Respiratory Disorder by Form – Revenue and Forecast to 2028 (US$ Million)
Table 135. Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Alzheimer’s Disease by Form – Revenue and Forecast to 2028 (US$ Million)
Table 136. Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Dementia by Form – Revenue and Forecast to 2028 (US$ Million)
Table 137. Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Renal Disease by Form – Revenue and Forecast to 2028 (US$ Million)
Table 138. Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Liver Failure by Form – Revenue and Forecast to 2028 (US$ Million)
Table 139. Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Post COVID-19 by Form – Revenue and Forecast to 2028 (US$ Million)
Table 140. Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Other Indications by Form – Revenue and Forecast to 2028 (US$ Million)
Table 141. Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Nutrition Type – Revenue and Forecast to 2028 (US$ Million)
Table 142. Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Form – Revenue and Forecast to 2028 (US$ Million)
Table 143. Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 144. Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 145. Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Age Group – Revenue and Forecast to 2028 (US$ Million)
Table 146. Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 147. Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 148. Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Gastrointestinal Disorders by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 149. Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Elderly by Form – Revenue and Forecast to 2028 (US$ Million)
Table 150. Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Gastrointestinal Disorders by Form – Revenue and Forecast to 2028 (US$ Million)
Table 151. Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For IBD by Form – Revenue and Forecast to 2028 (US$ Million)
Table 152. Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For IBS by Form – Revenue and Forecast to 2028 (US$ Million)
Table 153. Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Others by Form – Revenue and Forecast to 2028 (US$ Million)
Table 154. Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Diabetes by Form – Revenue and Forecast to 2028 (US$ Million)
Table 155. Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Cancer by Form – Revenue and Forecast to 2028 (US$ Million)
Table 156. Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Respiratory Disorder by Form – Revenue and Forecast to 2028 (US$ Million)
Table 157. Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Alzheimer’s Disease by Form – Revenue and Forecast to 2028 (US$ Million)
Table 158. Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Dementia by Form – Revenue and Forecast to 2028 (US$ Million)
Table 159. Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Renal Disease by Form – Revenue and Forecast to 2028 (US$ Million)
Table 160. Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Liver Failure by Form – Revenue and Forecast to 2028 (US$ Million)
Table 161. Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Post COVID-19 by Form – Revenue and Forecast to 2028 (US$ Million)
Table 162. Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Other Indications by Form – Revenue and Forecast to 2028 (US$ Million)
Table 163. Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Nutrition Type – Revenue and Forecast to 2028 (US$ Million)
Table 164. Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Form – Revenue and Forecast to 2028 (US$ Million)
Table 165. Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 166. Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 167. Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Age Group – Revenue and Forecast to 2028 (US$ Million)
Table 168. Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 169. Vietnam: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 170. Vietnam: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Gastrointestinal Disorders by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 171. Vietnam: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Elderly by Form – Revenue and Forecast to 2028 (US$ Million)
Table 172. Vietnam: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Gastrointestinal Disorders by Form – Revenue and Forecast to 2028 (US$ Million)
Table 173. Vietnam: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For IBD by Form – Revenue and Forecast to 2028 (US$ Million)
Table 174. Vietnam: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For IBS by Form – Revenue and Forecast to 2028 (US$ Million)
Table 175. Vietnam: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Others by Form – Revenue and Forecast to 2028 (US$ Million)
Table 176. Vietnam: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Diabetes by Form – Revenue and Forecast to 2028 (US$ Million)
Table 177. Vietnam: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Cancer by Form – Revenue and Forecast to 2028 (US$ Million)
Table 178. Vietnam: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Respiratory Disorder by Form – Revenue and Forecast to 2028 (US$ Million)
Table 179. Vietnam: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Alzheimer’s Disease by Form – Revenue and Forecast to 2028 (US$ Million)
Table 180. Vietnam: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Dementia by Form – Revenue and Forecast to 2028 (US$ Million)
Table 181. Vietnam: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Renal Disease by Form – Revenue and Forecast to 2028 (US$ Million)
Table 182. Vietnam: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Liver Failure by Form – Revenue and Forecast to 2028 (US$ Million)
Table 183. Vietnam: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Post COVID-19 by Form – Revenue and Forecast to 2028 (US$ Million)
Table 184. Vietnam: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Other Indications by Form – Revenue and Forecast to 2028 (US$ Million)
Table 185. Vietnam: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Nutrition Type – Revenue and Forecast to 2028 (US$ Million)
Table 186. Vietnam: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Form – Revenue and Forecast to 2028 (US$ Million)
Table 187. Vietnam: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 188. Vietnam: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 189. Vietnam: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Age Group – Revenue and Forecast to 2028 (US$ Million)
Table 190. Vietnam: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 191. Rest of Asia Pacific: Asia Pacific Enteral and Parenteral Medical Nutrition Market , by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 192. Rest of Asia Pacific: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Gastrointestinal Disorders by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 193. Rest of Asia Pacific: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Elderly by Form – Revenue and Forecast to 2028 (US$ Million)
Table 194. Rest of Asia Pacific: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Gastrointestinal Disorders by Form – Revenue and Forecast to 2028 (US$ Million)
Table 195. Rest of Asia Pacific: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For IBD by Form – Revenue and Forecast to 2028 (US$ Million)
Table 196. Rest of Asia Pacific: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For IBS by Form – Revenue and Forecast to 2028 (US$ Million)
Table 197. Rest of Asia Pacific: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Others by Form – Revenue and Forecast to 2028 (US$ Million)
Table 198. Rest of Asia Pacific: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Diabetes by Form – Revenue and Forecast to 2028 (US$ Million)
Table 199. Rest of Asia Pacific: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Cancer by Form – Revenue and Forecast to 2028 (US$ Million)
Table 200. Rest of Asia Pacific: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Respiratory Disorder by Form – Revenue and Forecast to 2028 (US$ Million)
Table 201. Rest of Asia Pacific: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Alzheimer’s Disease by Form – Revenue and Forecast to 2028 (US$ Million)
Table 202. Rest of Asia Pacific: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Dementia by Form – Revenue and Forecast to 2028 (US$ Million)
Table 203. Rest of Asia Pacific: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Renal Disease by Form – Revenue and Forecast to 2028 (US$ Million)
Table 204. Rest of Asia Pacific: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Liver Failure by Form – Revenue and Forecast to 2028 (US$ Million)
Table 205. Rest of Asia Pacific: Asia Pacific Enteral and Parenteral Medical Nutrition Market , For Post COVID-19 by Form – Revenue

LIST OF FIGURES

Figure 1. Asia Pacific Enteral and Parenteral Medical Nutrition Market Segmentation
Figure 2. Asia Pacific Enteral and Parenteral Medical Nutrition Market, By Country
Figure 3. Asia Pacific Enteral and Parenteral Medical Nutrition Market Overview
Figure 4. Elderly Segment Held Largest Share of Indication Segment in Asia Pacific Enteral and Parenteral Medical Nutrition Market
Figure 5. India is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Asia Pacific: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Impact Analysis
Figure 9. Asia Pacific Enteral and Parenteral Medical Nutrition Market- Revenue Forecast and Analysis – 2020- 2028
Figure 10. Asia Pacific Enteral and Parenteral Medical Nutrition Market Revenue Share, by Indication 2022 & 2028 (%)
Figure 11. Elderly: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Gastrointestinal Disorders: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. IBD: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. IBS: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Others: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Diabetes: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Cancer: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Respiratory Disorders: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Alzheimer’s Disease: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Dementia: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Renal Disease: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Liver Failure: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Post COVID-19: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Other Indications: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Asia Pacific Enteral and Parenteral Medical Nutrition Market Revenue Share, by Nutrition Type 2022 & 2028 (%)
Figure 26. Supplemental: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Sole Source: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Asia Pacific Enteral and Parenteral Medical Nutrition Market Revenue Share, by Form 2022 & 2028 (%)
Figure 29. Liquid: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Powder: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Semi-Solid: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Asia Pacific Enteral and Parenteral Medical Nutrition Market Revenue Share, by Product Type 2022 & 2028 (%)
Figure 33. General: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Disease Specific: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Asia Pacific Enteral and Parenteral Medical Nutrition Market Revenue Share, by Route of Administration 2022 & 2028 (%)
Figure 36. Oral: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Tube Feed: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Parenteral: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. Asia Pacific Enteral and Parenteral Medical Nutrition Market Revenue Share, by Age Group 2022 & 2028 (%)
Figure 40. Above 60 Years: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41.-60 Years: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. 3-18 Years: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. Below 3 Years: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. Asia Pacific Enteral and Parenteral Medical Nutrition Market Revenue Share, by Distribution Channel 2022 & 2028 (%)
Figure 45. Hospital Pharmacies: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. Retail Stores: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 47. E-Commerce: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 48. Others: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 49. Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Key Country – Revenue (2022) (US$ Million)
Figure 50. Asia Pacific Enteral and Parenteral Medical Nutrition Market, by Country, 2022 & 2028 (%)
Figure 51. China: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 52. Japan: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 53. India: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 54. Australia: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 55. South Korea: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 56. Indonesia: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 57. Thailand: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 58. Vietnam: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 59. Rest of Asia Pacific: Asia Pacific Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
Figure 60. Growth Strategies in the Asia Pacific Enteral and Parenteral Medical Nutrition Market

The List of Companies – Asia Pacific Enteral and Parenteral Medical Nutrition Market

– Abbott Laboratories
– B. Braun SE
– Baxter International Inc
– Fresenius Kabi AG
– Nestle SA
– Nutricia International BV

Reviews

There are no reviews yet.

Be the first to review “Asia Pacific Enteral and Parenteral Medical Nutrition Market Forecast to 2028”